Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 1;23(7):2523-2530.
doi: 10.31557/APJCP.2022.23.7.2523.

Dual Targeting of Anti-Apoptotic Proteins Enhances Chemosensitivity of the Acute Myeloid Leukemia Cells

Behzad Baradaran  1 , Roya Nazmabadi  2 , Zohreh Ariyan  3 , Ebrahim Sakhinia  4 , Hadi Karami  5
Affiliations

Dual Targeting of Anti-Apoptotic Proteins Enhances Chemosensitivity of the Acute Myeloid Leukemia Cells

Behzad Baradaran et al. Asian Pac J Cancer Prev. .

Abstract

Background: Acute myeloid leukemia (AML) is a type of blood cancer characterized by fast cellular proliferation. Myeloid cell leukemia-1 (Mcl-1) and survivin, as anti-apoptotic proteins, are involved in cancer growth and resistance to chemotherapy. The aim of this study was to examine the combination effect of Mcl-1 and survivin specific siRNAs on chemosensitivity of the human HL-60 AML cells.

Methods: SiRNAs transfection was performed by using Lipofectamine™2000 reagent. The mRNA expression was analyzed by real-time quantitative PCR. The apoptosis analysis was measured by ELISA cell death assay.

Results: siRNAs markedly suppressed mRNA expression levels of Mcl-1 and survivin in a time-dependent manner, resulting in reduction of leukemic cell proliferation and enhanced spontaneous cell death. Surprisingly, Mcl-1 siRNA and survivin siRNA synergistically enhanced the cell toxic effects of etoposide. Furthermore, down-regulation of Mcl-1 and survivin significantly enhanced the apoptotic effect of etoposide.

Conclusions: Our investigation suggests that suppression of Mcl-1 and survivin by siRNA can effectually inhibit cell growth and overcome chemoresistance of AML cells. Therefore siRNAs may be an important adjuvant in chemotherapy for AML patients.

Keywords: Etoposide; Mcl-1; Survivin; acute myeloid leukemia; siRNA.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to declare.

Figures

Figure 1
Figure 1
Mcl-1 and Survivin Expression Analysis in HL-60 Cells Treated with siRNA. The cells were transfected with NC siRNA, Mcl-1 siRNA and survivin siRNA for 24 and 48 h, and then relative Mcl-1 (A) and survivin (B) mRNA expression was measured by RT-qPCR. The results are expressed as mean±SD of three independent experiments. *p<0.05 versus blank control group or NC siRNA transfected cells
Figure 2
Figure 2
Effect of siRNAs in Combination with Etoposide on Cell Survival. The HL-60 cells were transfected with siRNA for 6 h and then exposed to etoposide at indicated concentrations. Twenty-four hours after transfection, the cell survival was measured using MTT assay. The cell survival curves were plotted by GraphPad software (A, B and C). Data are showed as mean ± SD of three experiments. The combination index (CI) values were calculated using the fractional affected (Fa) values of MTT assay and CalcuSyn software (D, E, F and G)
Figure 3
Figure 3
Proliferation Inhibition of HL-60 Leukemic Cells. The HL-60 cells were transfected with NC siRNA, Mcl-1 siRNA and survivin siRNA for 1-5 day, and the cell proliferation rate was measured using trypan blue assay at the end of each day. The data are represented as mean±SD of three experiments. *p<0.05 versus blank control or NC siRNA
Figure 4
Figure 4
The Effect of siRNAs and Etoposide on Apoptosis of HL-60 Cells. Cells were treated with negative control (NC) siRNA, Mcl-1 siRNA, survivin siRNA and etoposide (IC50 doses of 24 h), alone and in combination. Next, apoptosis was assessed using ELISA cell death assay. The data are presented as mean ± SD (n=3). *p<0.05 relative to the control; #p<0.05 versus single transfection; $ p<0.05 relative to siRNA in combination with etoposode
See this image and copyright information in PMC

References

    1. Akagi H, Higuchi H, Sumimoto H, et al. Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cells. Gastric Cancer. 2013;16:100–10. - PubMed
    1. Alamdari-Palangi V, Amini R, Karami H. MiRNA-7 enhances erlotinib sensitivity of glioblastoma cells by blocking the IRS-1 and IRS-2 expression. J Pharm Pharmacol. 2020;72:531–38. - PubMed
    1. Amri J, Molaee N, Karami H. Up-Regulation of MiRNA-125a-5p Inhibits Cell Proliferation and Increases EGFR-TKI Induced Apoptosis in Lung Cancer Cells. Asian Pac J Cancer Prev. 2019;20:3361–67. - PMC - PubMed
    1. Ashofteh N, Amini R, Molaee N, et al. MiRNA-Mediated Knock-Down of Bcl-2 and Mcl-1 Increases Fludarabine-Sensitivity in CLL-CII Cells. Asian Pac J Cancer Prev. 2021;22:2191–98. - PMC - PubMed
    1. Balaji S, Terrero D, Tiwari AK, et al. Alternative approaches to overcome chemoresistance to apoptosis in cancer. Adv Protein Chem Struct Biol. 2021;126:91–122. - PubMed

MeSH terms